Biblio

Export 3285 results:
Author Title Type [ Year(Desc)]
Filters: Filter is   [Clear All Filters]
2024
I. J. Sible and Nation, D. A., “Blood Pressure Variability and Plasma Alzheimer's Disease Biomarkers in the SPRINT Trial.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1851-1860, 2024.
I. K. Gorham, Reid, D. Marie, Sun, J., Zhou, Z., Barber, R. C., and Phillips, N. R., “Blood-Based mtDNA Quantification Indicates Population-Specific Differences Associated with Alzheimer's Disease-Related Risk.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1407-1419, 2024.
W. B. Grant, “A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. s1, pp. S165-S178, 2024.
Y. Zeng, Cao, S., Pang, K., Tang, J., and Lin, G., “Causal Association Between Sepsis and Neurodegenerative Diseases: A Bidirectional Two-Sample Mendelian Randomization Study.”, J Alzheimers Dis, vol. 97, no. 1, pp. 229-237, 2024.
D. Li, Xie, Q., Xie, J., Ni, M., Wang, J., Gao, Y., Wang, Y., and Tang, Q., “Cerebrospinal Fluid Proteomics Identifies Potential Biomarkers for Early-Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 1, pp. 261-277, 2024.
P. P. Chum, Bishara, M. A., Solis, S. R., and Behringer, E. J., “Cerebrovascular miRNAs Track Early Development of Alzheimer's Disease and Target Molecular Markers of Angiogenesis and Blood Flow Regulation.”, J Alzheimers Dis, vol. 99, no. s2, pp. S187-S234, 2024.
J. Wang, Zhang, G., Lai, H., Li, Z., Shen, M., Li, C., Kwan, P., O'Brien, T. J., Wu, T., Yang, S., Zhang, X., and Zhang, L., “Characterizing Gut Microbiota in Older Chinese Adults with Cognitive Impairment: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 761-771, 2024.
C. L. Satizabal, Himali, J. Jung, Conner, S. C., Beiser, A. S., Maillard, P., Vasan, R. S., DeCarli, C., and Seshadri, S., “Circulating adipokines and MRI markers of brain aging in middle-aged adults from the community.”, J Alzheimers Dis, vol. 102, no. 2, pp. 449-458, 2024.
C. Rosario Ilardi, Menichelli, A., Michelutti, M., Cattaruzza, T., Federico, G., Salvatore, M., Iavarone, A., and Manganotti, P., “On the Clinimetrics of the Montreal Cognitive Assessment: Cutoff Analysis in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.”, J Alzheimers Dis, vol. 101, no. 1, pp. 293-308, 2024.
A. Giudicessi, McDowell, C. Pluim, Martinez, J. E., Baena, A., Vila-Castelar, C., Norton, D., Aguirre-Acevedo, D. C., Tirado, V., Bocanegra, Y., Guzmán-Vélez, E., Lopera, F., Cronin-Golomb, A., and Quiroz, Y. T., “Cognitive Outcomes in Autosomal-Dominant Alzheimer's Disease: A Comprehensive Review from a Colombian Kindred with the Presenilin-1 E280A Mutation.”, J Alzheimers Dis, vol. 101, no. 2, pp. 397-415, 2024.
F. Leng, Hinz, R., Gentleman, S., Dani, M., Brooks, D. J., and Edison, P., “Combined Neuroinflammation and Amyloid PET Markers in Predicting Disease Progression in Cognitively Impaired Subjects.”, J Alzheimers Dis, vol. 100, no. 3, pp. 973-986, 2024.
L. Fernández-Romero, Morello-García, F., Laforce, R., Delgado-Alonso, C., Delgado-Álvarez, A., Gil-Moreno, M. José, Lavoie, M., Matías-Guiu, J., Cuetos, F., and Matías-Guiu, J. A., “Comparative accuracy of Mini-Linguistic State Examination, Addenbrooke's Cognitive Examination, and Depistage Cognitif de Quebec for the diagnosis of primary progressive aphasia.”, J Alzheimers Dis, vol. 102, no. 1, pp. 67-76, 2024.
I. Terao and Kodama, W., “Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease”, J Alzheimers Dis, vol. 98, no. 3, pp. 825-835, 2024.
M. Kurano, Saito, Y., and Yatomi, Y., “Comprehensive Analysis of Metabolites in Postmortem Brains of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1139-1159, 2024.
N. Puentes-Díaz, Chaparro, D., Reyes-Marquez, V., Morales-Morales, D., Flores-Gaspar, A., and Alí-Torres, J., “Computational Evaluation of the Potential Pharmacological Activity of Salen-Type Ligands in Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S383-S396, 2024.
A. Mahzarnia, Lutz, M. W., and Badea, A., “A Continuous Extension of Gene Set Enrichment Analysis Using the Likelihood Ratio Test Statistics Identifies Vascular Endothelial Growth Factor as a Candidate Pathway for Alzheimer's Disease via ITGA5.”, J Alzheimers Dis, vol. 97, no. 2, pp. 635-648, 2024.
N. Vaishnav, Gonzalez, R., Karunungan, K., Tyler, A., Zheng, W., and Arias, J. J., “Creating an Unprotected Class: Addressing Legal Risks in the Era of Biologically-Defined Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 1, pp. 187-195, 2024.
V. Michelle M. Anlacan, Lanuza, P. Danielle T., Sanchez, A. Anjelica R., and Jamora, R. Dominic G., “Current Status and Challenges in Dementia Care in the Philippines: A Scoping Review.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1533-1543, 2024.
W. Dombrowski, Mims, A., Kremer, I., Desandes, P. Cano, Rodrigo-Herrero, S., Epps, F., Snow, T., Gutierrez, M., Nasta, A., Epperly, M. Bunce, Manaloto, K., and Hansen, J. Chin, “Dementia Ideal Care: Ecosystem Map of Best Practices and Care Pathways Enhanced by Technology and Community.”, J Alzheimers Dis, vol. 100, no. 1, pp. 87-117, 2024.
C. E. Finch and Burstein, S. M., “Dementia in the Ancient Greco-Roman World Was Minimally Mentioned.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1581-1588, 2024.
B. Portal, Södergren, M., Borrell, T. Parés I., Giraud, R., Metzendorf, N. G., Hultqvist, G., Nilsson, P., and Lindskog, M., “Early Astrocytic Dysfunction Is Associated with Mistuned Synapses as well as Anxiety and Depressive-Like Behavior in the AppNL-F Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 100, no. 3, pp. 1017-1037, 2024.
M. S. Weinberg, He, Y., Kivisäkk, P., Arnold, S. E., and Das, S., “Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. s2, pp. S355-S365, 2024.
T. Chatzikostopoulos, Gialaouzidis, M., Koutoupa, A., and Tsolaki, M., “The Effects of Pomegranate Seed Oil on Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1961-1970, 2024.
H. Shimada, Doi, T., Tsutsumimoto, K., Makino, K., Harada, K., Tomida, K., and Arai, H., “Elevated Risk of Dementia Diagnosis in Older Adults with Low Frequencies and Durations of Social Conversation.”, J Alzheimers Dis, vol. 98, no. 2, pp. 659-669, 2024.
X. Liang, Wang, Y., Li, S., Fan, J., Zhou, F., Li, X., Li, S., and Li, Y., “Enhancing Rab7 Activity by Inhibiting TBC1D5 Expression Improves Mitophagy in Alzheimer's Disease Models.”, J Alzheimers Dis, vol. 100, no. 1, pp. 279-296, 2024.

Pages